D Trademark
Trademark Overview
On Thursday, January 20, 2022, a trademark application was filed for D with the United States Patent and Trademark Office. The USPTO has given the D trademark a serial number of 97229686. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, June 12, 2026. This trademark is owned by Diamond Therapeutics Inc.. The D trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Advertising, Business and Retail Services, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:
Licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses, and disorders
Wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses and disorders
Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer software applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; medical systems comprising recorded and downloadable software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical alert response systems comprising recorded and downloadable software and/or hardware for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a Medical ...
Pharmaceutical preparations for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical products for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical preparations for the treatment of mental conditions, illnesses, and disorders; pharmaceutical drugs for the treatment of mental conditions, illnesses, and disorders; psychedelic pharmaceuticals for the treatment of central nervous system conditions, illnesses, and disorders; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative pharmaceutical drugs for the treatment of central nervous system [CNS] diseases and mental health disorders; serotonin receptor agonists and antagonist pharmaceutical drugs for the treatment of central nervous system [CNS] diseases and mental health disorders; drug abuse deterrent products in the nature of low-dose pharmaceutical preparations and products, very low...
Pharmaceutical research and development; pharmaceutical drug development; pharmaceutical research and development in the field of mental health treatments; drug discovery services; consultancy pertaining to pharmacology; medical research in the field of mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services, including pre-clinical and clinical pharmaceutical drug development; pharmaceutical drug development and discovery relating to new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms
Electroencephalogram (EEG) devices, namely, electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of pharmaceuticals; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices for use in therapy of cognitive states, namely, to monitor, sense, or measure cognitive impairment during use of pharmaceuticals; medical devices for stimulating nerves; medical device used for treating of mental health disorders non-invasively, namely, comprising a sensor for monitoring and measuring brain and neural activity; medical device used in combination with pharmaceutical preparations for treating of mental health disorders non-invasively, namely, for monitoring, sensing, stimulating, measuring, and training brain and neural activity
Custom manufacture for others of pharmaceuticals, pharmaceutical drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; custom manufacture for others of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to treat mental conditions, illnesses and disorders
General Information
| Serial Number | 97229686 |
| Word Mark | D |
| Filing Date | Thursday, January 20, 2022 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, June 12, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of upper case letter "D" with a diamond shape positioned along its vertical spine. |
| Goods and Services | Licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; licensing of intellectual property in the field of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses, and disorders |
| Goods and Services | Wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to improve, treat, and prevent diseases, disorders, conditions, and ailments; wholesale distributorship featuring pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products used to treat mental conditions, illnesses and disorders |
| Goods and Services | Downloadable computer applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable computer software applications for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable computer software applications for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; medical systems comprising recorded and downloadable software and/or hardware for monitoring, sensing, stimulating, measuring, and training brain and neural activity; medical alert response systems comprising recorded and downloadable software and/or hardware for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a Medical Device (SaMD) for monitoring, sensing, stimulating, measuring, and training brain and neural activity; downloadable software as a Medical Device (SaMD) for use in therapy of cognitive states to monitor, sense, and measure cognitive impairment during use of pharmaceuticals; downloadable software as a Medical Device (SaMD) for stimulating nerves |
| Goods and Services | Pharmaceutical preparations for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical products for the treatment of central nervous system conditions, illnesses, and disorders; pharmaceutical preparations for the treatment of mental conditions, illnesses, and disorders; pharmaceutical drugs for the treatment of mental conditions, illnesses, and disorders; psychedelic pharmaceuticals for the treatment of central nervous system conditions, illnesses, and disorders; psychedelic-based medicines for the treatment of central nervous system conditions, illnesses, and disorders; neurogenerative pharmaceutical drugs for the treatment of central nervous system [CNS] diseases and mental health disorders; serotonin receptor agonists and antagonist pharmaceutical drugs for the treatment of central nervous system [CNS] diseases and mental health disorders; drug abuse deterrent products in the nature of low-dose pharmaceutical preparations and products, very low-dose pharmaceutical preparations and products, extended release pharmaceutical preparations and products, and tamper resistant pharmaceutical preparations and products; pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms, namely, motivation, attention, accuracy, response speed, perseverance, cognitive engagement, executive function, mood, and/or behavior; pharmaceutical preparations for use in psychedelic therapies for the treatment of mental health disorders; |
| Goods and Services | Pharmaceutical research and development; pharmaceutical drug development; pharmaceutical research and development in the field of mental health treatments; drug discovery services; consultancy pertaining to pharmacology; medical research in the field of mental health conditions, illnesses, and disorders; neuropsychiatric drug discovery services, including pre-clinical and clinical pharmaceutical drug development; pharmaceutical drug development and discovery relating to new chemical entities, neurogenerative drugs, serotonin receptor agonists and antagonist, abuse deterrent drugs, and pharmaceutical preparations for managing a mental, a behavioral, or a neuropsychiatric condition, or its symptoms |
| Goods and Services | Electroencephalogram (EEG) devices, namely, electroencephalography (EEG) device comprising a sensor for monitoring and measuring brain and neural activity for medical diagnostic purposes during use of pharmaceuticals; medical devices for monitoring, sensing, measuring, and training brain and neural activity; medical devices for use in therapy of cognitive states, namely, to monitor, sense, or measure cognitive impairment during use of pharmaceuticals; medical devices for stimulating nerves; medical device used for treating of mental health disorders non-invasively, namely, comprising a sensor for monitoring and measuring brain and neural activity; medical device used in combination with pharmaceutical preparations for treating of mental health disorders non-invasively, namely, for monitoring, sensing, stimulating, measuring, and training brain and neural activity |
| Goods and Services | Custom manufacture for others of pharmaceuticals, pharmaceutical drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to improve, treat and prevent diseases, disorders, conditions, and ailments; custom manufacture for others of pharmaceuticals, drugs, pharmaceutical preparations and products, and health care products, namely, central nervous system health care products used to treat mental conditions, illnesses and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 2, 2022 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 2, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 2, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 2, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 2, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 2, 2022 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Diamond Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Toronto M5C2C5
CA |
Trademark Events
| Event Date | Event Description |
| Monday, January 24, 2022 | NEW APPLICATION ENTERED |
| Wednesday, February 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 3, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, October 29, 2022 | ASSIGNED TO EXAMINER |
| Thursday, November 3, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, November 3, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, November 3, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 3, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 3, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 24, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 24, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 24, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 18, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 19, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 14, 2023 | SUSPENSION LETTER WRITTEN |
| Thursday, September 14, 2023 | LETTER OF SUSPENSION E-MAILED |
| Thursday, September 14, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, March 15, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, April 4, 2024 | SUSPENSION INQUIRY WRITTEN |
| Thursday, April 4, 2024 | INQUIRY TO SUSPENSION E-MAILED |
| Thursday, April 4, 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, June 26, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, June 26, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 26, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 17, 2024 | SUSPENSION LETTER WRITTEN |
| Wednesday, July 17, 2024 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, July 17, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 15, 2025 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, January 15, 2025 | INQUIRY TO SUSPENSION E-MAILED |
| Wednesday, January 15, 2025 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Monday, April 14, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, April 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 23, 2025 | SUSPENSION LETTER WRITTEN |
| Wednesday, April 23, 2025 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, April 23, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, October 28, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, January 12, 2026 | SUSPENSION INQUIRY WRITTEN |
| Monday, January 12, 2026 | INQUIRY TO SUSPENSION E-MAILED |
| Monday, January 12, 2026 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Thursday, April 9, 2026 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, April 14, 2026 | ASSIGNED TO LIE |
| Wednesday, April 15, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 15, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 6, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 6, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 6, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, May 14, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 14, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 15, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 12, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, June 12, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Friday, June 12, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Friday, June 12, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, June 12, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
